Price analysis NEOLA®
Reference number | |
Coordinator | GPX Medical AB |
Funding from Vinnova | SEK 183 146 |
Project duration | May 2022 - November 2022 |
Status | Completed |
Venture | Medtech4Health: Competence Enhancement in SME |
Call | Medtech4Health: Skills enhancement in small businesses 2022 |
Important results from the project
** Denna text är maskinöversatt ** The purpose of the project was to carry out a price analysis to get an understanding of how potential price levels for NEOLA® affected the market´s willingness to purchase the product. The price analysis has given the Company exactly the understanding it sought. Today, the Company knows what price levels the American market can tolerate and the expected impact NEOLA® can have on the American market.
Expected long term effects
The project gives GPX Medical a much stronger foundation to be able to achieve international success in the United States by laying the foundation for commercialization in the American market. In addition, the company´s competitiveness is strengthened as the right knowledge of the willingness to pay for different price models means that the company can set the right price level for NEOLA®.
Approach and implementation
The project is closely linked to our commercialization strategy for the US market and the work included: - Cost analysis of NEOLA® - Development of various potential price models and price levels for evaluation - Implementation and analysis of a potential market research buyer - Development of final initial sales price and payment model for NEOLA® - Implementation of project insights in the market strategy for the US market